Spots Global Cancer Trial Database for Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Official Title: Observational, Noninterventional Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Study ID: NCT01194284
Conditions
Interventions
Study Description
Brief Summary: This study is an observational safety surveillance study designed to prospectively assess patients with high-grade osteosarcoma who are candidates for treatment with mifamurtide within the context of prevailing standard oncology practice
Detailed Description:
Keywords
Eligibility
Minimum Age: 2 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
AKH Wien Universitätsklinik für Innere Medizin I Klinische Abteilung für Onkologie, Wien, , Austria
Contact Details
Name: Medical Monitor
Affiliation: Millennium Pharmaceuticals, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
